Somerset's Low-Dose Emsam Patch Needs Dietary Restrictions, FDA Reviewer Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Dietary restrictions for the 20 mg patch of the therapy for major depressive disorder will be reviewed by the Psychopharmacologic Drugs Advisory Committee on Oct. 26.
You may also be interested in...
Somerset Low-Dose Emsam Does Not Need Dietary Restrictions, Committee Says
FDA’s Psychopharmacologic Drugs Advisory Committee votes that 20 mg monoamine oxidase inhibitor patch can be marketed without dietary restrictions even if higher dosage strengths of Emsam require them.
Somerset Low-Dose Emsam Does Not Need Dietary Restrictions, Committee Says
FDA’s Psychopharmacologic Drugs Advisory Committee votes that 20 mg monoamine oxidase inhibitor patch can be marketed without dietary restrictions even if higher dosage strengths of Emsam require them.